AI Modules for Improving Social Communication in Autism

N/A

Recruiting

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age between 11 to 35

Primary diagnosis of autism spectrum disorder (ASD)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up approximately 9 weeks per participant (4 weeks of intervention + pre and post measures + 1-month follow-up)

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if AI can effectively deliver interventions for individuals with autism spectrum disorder who struggle with socialization. The study will use an app on a phone or computer to provide practice and feedback on

Who is the study for?

This trial is for verbal individuals aged 11 to 35 with autism spectrum disorder who struggle with social conversations. Participants must be able to speak in full sentences and have specific communication challenges, like empathy. Those with ADHD, depression, or social anxiety can also join.

What is being tested?

The study tests if AI modules on phones or computers can improve social conversation skills in people with ASD. It uses voice recognition and feedback to practice real-life interactions and aims to offer accessible care at home.

What are the potential side effects?

Since this intervention involves AI software rather than medication, traditional physical side effects are not expected. However, participants may experience frustration or fatigue from regular use of the application.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 11 and 35 years old.

Select...

I have been diagnosed with autism spectrum disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ approximately 9 weeks per participant (4 weeks of intervention + pre and post measures + 1-month follow-up)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~approximately 9 weeks per participant (4 weeks of intervention + pre and post measures + 1-month follow-up)

This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 9 weeks per participant (4 weeks of intervention + pre and post measures + 1-month follow-up) for reporting.